Nevro Corp

NYSE:NVRO USA Medical Devices
Market Cap
$224.09 Million
Market Cap Rank
#15035 Global
#5964 in USA
Share Price
$5.84
Change (1 day)
+0.00%
52-Week Range
$5.77 - $5.85
All Time High
$184.34
About

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well a… Read more

Nevro Corp (NVRO) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2024: 0.080x

Based on the latest financial reports, Nevro Corp (NVRO) has a cash flow conversion efficiency ratio of 0.080x as of December 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($18.59 Million) by net assets ($231.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nevro Corp - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Nevro Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Nevro Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nevro Corp ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Nevro Corp (2012–2024)

The table below shows the annual cash flow conversion efficiency of Nevro Corp from 2012 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $231.01 Million $-19.44 Million -0.084x +58.07%
2023-12-31 $293.14 Million $-58.83 Million -0.201x -363.41%
2022-12-31 $323.88 Million $24.68 Million 0.076x +155.23%
2021-12-31 $303.62 Million $-41.88 Million -0.138x -4599.11%
2020-12-31 $388.46 Million $1.19 Million 0.003x +101.32%
2019-12-31 $216.35 Million $-50.23 Million -0.232x -898.38%
2018-12-31 $245.48 Million $-5.71 Million -0.023x +59.41%
2017-12-31 $249.17 Million $-14.27 Million -0.057x +75.62%
2016-12-31 $249.03 Million $-58.50 Million -0.235x +45.13%
2015-12-31 $234.59 Million $-100.43 Million -0.428x -136.50%
2014-12-31 $172.07 Million $-31.15 Million -0.181x +42.12%
2013-12-31 $67.44 Million $-21.09 Million -0.313x +39.28%
2012-12-31 $43.61 Million $-22.47 Million -0.515x --